Skip to product information
1 of 1

Elabscience

SKU:PKSH033978

Recombinant Human Leukocyte Ig-Like Receptor B1/ LILRB1/ILT2/CD85j (C-Fc)

Recombinant Human Leukocyte Ig-Like Receptor B1/ LILRB1/ILT2/CD85j (C-Fc)

Regular price $200.00 USD
Regular price Sale price $200.00 USD
Sale Sold out
Shipping calculated at checkout.
Size
Introducing the Recombinant Human Leukocyte IG-Like Receptor B1, also known as LILRB1, ILT2, or CD85J (C-FC). This meticulously crafted product is designed to cater to the discerning needs of the scientific community, offering a cutting-edge solution for various research applications.

The Recombinant Human Leukocyte IG-Like Receptor B1 showcases an exceptional level of precision and quality, ensuring reliable and reproducible results. With its advanced technology and rigorous manufacturing process, this product guarantees optimal performance and accuracy in experimental settings.

This versatile receptor exhibits a remarkable affinity for its ligands, enabling comprehensive investigations into cellular interactions and immune responses. Its multifaceted nature allows for a wide range of applications, including but not limited to immunology, cell biology, and molecular biology research.

Crafted with utmost care, the Recombinant Human Leukocyte IG-Like Receptor B1 embodies the pinnacle of scientific innovation. Its unrivaled specificity and sensitivity empower researchers to delve deeper into the intricacies of immune regulation and cellular signaling pathways.

Furthermore, this product adheres to the highest industry standards, ensuring utmost purity and stability. Its consistent performance and long shelf life make it an indispensable tool for laboratories and institutions striving for excellence in their scientific endeavors.

In summary, the Recombinant Human Leukocyte IG-Like Receptor B1, also known as LILRB1, ILT2, or CD85J (C-FC), is a remarkable scientific breakthrough. With its exceptional quality, versatility, and reliability, it serves as an invaluable asset for researchers seeking to unravel the complexities of immune responses and cellular interactions.
View full details